Botfet / Company detail

INDV

rejected

Indivior Pharmaceuticals Inc

biotech

Moat scoreNot available: not scored quality failout of 100

Rejectionquality_fail

The numbers

Financial metrics

Quality gate and thesis context

Roic70.8%

Gross Margin80.2%

Revenue Cagr11.9%

Fcf Conversion-44.8%

Fcf Yield-2.2%

Interest Coverage6.8x

Market Cap B$4.3B

Pe12.1

Quality PassFail

Founder LedNo

Thesis AlignedYes

Moat QuantNot available: not scored quality fail

Why it may endure

Quant: · Curator:

Market Share StabilityNot available: not scored quality fail

Network EffectsNot available: not scored quality fail

Pricing PowerNot available: not scored quality fail

Regulatory MoatNot available: not scored quality fail

Switching CostsNot available: not scored quality fail

ConvictionNot available: not scored quality fail

LeadershipNot available: not scored quality fail

VisionNot available: not scored quality fail